Order Article Reprints

Heiblig M, Duployez N, Marceau A, Lebon D, Goursaud L, Plantier I, Stalnikiewich L, Cambier N, Balsat M, Fossard G, et al. The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively. Cancers. 2021; 13(9):2156. https://doi.org/10.3390/cancers13092156

Heiblig, Maël, Nicolas Duployez, Alice Marceau, Delphine Lebon, Laure Goursaud, Isabelle Plantier, Laure Stalnikiewich, Nathalie Cambier, Marie Balsat, Gaëlle Fossard, and et al. 2021. "The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively" Cancers 13, no. 9: 2156. https://doi.org/10.3390/cancers13092156

Heiblig, M., Duployez, N., Marceau, A., Lebon, D., Goursaud, L., Plantier, I., Stalnikiewich, L., Cambier, N., Balsat, M., Fossard, G., Labussière-Wallet, H., Barraco, F., Ducastelle-Lepretre, S., Sujobert, P., Huet, S., Hayette, S., Ghesquières, H., Thomas, X., & Preudhomme, C. (2021). The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively. Cancers, 13(9), 2156. https://doi.org/10.3390/cancers13092156